latest news
News2026-06-18T11:13:44-07:00

Stories & Trends in Respiratory Nasal Sampling

Chief Technology Officer Dr. Thanh Nguyen Earns University of Nebraska’s Prestigious President’s Excellence Award for Faculty Intellectual Property, Innovation & Commercialization

Dr. Nguyen, the lead designer and developer of MicroWash, recently received the esteemed FIPICA distinction. This award recognizes faculty who have successfully nurtured significant intellectual property from concept to licensing.

General|

Chief Medical Officer Michael Wadman, MD, FACEP, Examines Key Causes, Outcomes & Solutions for Post-Pandemic Test Avoidance in MedCity News

In an article for MedCity News, Dr. Wadman sheds light on the “why” behind post-pandemic URI testing avoidance. As nasal swabs continue to deter patients due to discomfort, injury risks and other complications, explore how evolved nasal lavage methods like MicroWash could be a key solution for boosting testing volumes.

General|

The Underestimated Safety Risks of Nasal Swab Specimen Collection (And How to Eliminate Them)

Nasal swab specimen collection remains the default for URI testing — but its safety, sensitivity and scalability often fall short. Explore key risks for patients, providers and labs, and see why evolved nasal lavage solutions are a more reliable collection method for today’s testing demands.

General|

Chief Medical Officer Michael Wadman, MD, FACEP, Explores the Evolving Role of Nasal Lavage in URI Testing for Patient Safety & Quality Healthcare

Dr. Wadman recently authored an article for Patient Safety & Quality Healthcare highlighting the need to adapt specimen collection for modern URI testing. He explores how evolved nasal lavage provides safer and more comfortable sampling with higher sensitivity, addressing nasal swab limitations while enhancing outbreak readiness.

General|

Chief Medical Officer Michael Wadman, MD, FACEP, & Chief Technology Officer Thanh Nguyen, PhD, MSN, FNP-C, Spotlighted in Silicon Prairie News Following Nationwide Launch of MicroWash

With MicroWash now commercially available for U.S. healthcare providers, Silicon Prairie News featured two of the biggest innovators behind it. Dr. Wadman and Dr. Nguyen shared how their experience on the COVID-19 frontlines led to a more scalable, safe and sensitive nasal sampling approach compared to the swab.

General|

Are Nasal Swabs Hurting Your Lab Automation & Throughput?

Nasal swabs were the go-to sampling method during COVID-19 — but at what cost? Broken-off swabs, inconsistent specimen quality and human error took a toll on automation. Take a closer look at what’s really slowing labs down, and how evolved nasal lavage solutions can seamlessly help you achieve higher throughput.

General|

The New Antigen Test Alternative: Pairing PCR with a Better Sampling Device

Antigen tests helped carry us through the pandemic, but they’re no longer the gold standard in URI diagnostics — especially among high-risk populations. Dive into key differences of PCR versus antigen testing and see why PCR paired with MicroWash is a reliable, comfortable solution for yielding more reliable diagnoses, sooner.

General|

Chief Executive Officer Nicholas Lorenzo, MD, MHCM, CPE, FAAPL, & Chief Medical Officer Michael Wadman, MD, FACEP, Spotlight the Potential of Evolved Nasal Lavage to Revolutionize URI Sampling in Today’s Clinical Lab

In a recent article, Dr. Lorenzo and Dr. Wadman share insights on why highly sensitive nasal lavage could soon replace nasal swabs as the frontline sampling solution in clinical settings.

General|

URI Needs Better Testing Samples, Especially with the Threat of New Pathogens

The height of the COVID-19 crisis may be behind us, but URIs aren’t going anywhere. Discover how pandemic learnings and up-and-coming specimen collection solutions have given us an opportunity to reimagine effective URI pathogen identification, both now and in the future.

General|
Go to Top